Results 271 to 280 of about 186,531 (283)
Some of the next articles are maybe not open access.
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
New England Journal of MedicineBACKGROUND Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker-based diagnosis of myocardial infarction and ...
T. Yndigegn +18 more
semanticscholar +1 more source
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.
New England Journal of MedicineBACKGROUND The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies.
J. Munkhaugen +63 more
semanticscholar +1 more source
Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis
Oncology, 2017Hyun Yul Kim +4 more
semanticscholar +1 more source
Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient.
Journal of the American Society of Hypertension : JASH, 2017S. Mann
semanticscholar +1 more source
Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters
Gut, 2016Basile Njei +2 more
semanticscholar +1 more source
Beta-blocker use in severe sepsis and septic shock: a systematic review
Current Medical Research and Opinion, 2015F. Sanfilippo +3 more
semanticscholar +1 more source
Stage‐specific associations between beta blocker use and prognosis after colorectal cancer
Cancer, 2014L. Jansen +4 more
semanticscholar +1 more source

